✦ LIBER ✦

The binding of actin to p38 MAPK and inhibiting its kinase activityin vitro

✍ Scribed by Kun Yang; Yong Jiang; Jiahuai Han; Jun Gu

Book ID: 105726904
Publisher: Science in China Press (SCP)
Year: 2003
Tongue: English
Weight: 625 KB
Volume: 46
Category: Article
ISSN: 1674-7305
DOI: 10.1007/bf03182688

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Binding of vanadyl ions to G-actin and i

Binding of vanadyl ions to G-actin and its impact on the polymerization of G-actin

✍ Boyan Zhang; Kui Wang; Fang An; Baowei Chen 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Spectrin-4.1-actin complex of the human

Spectrin-4.1-actin complex of the human erythrocyte: Molecular basis of its ability to bind cytochalasins with high-affinity and to accelerate actin polymerization in vitro

✍ Lin, Diane Chang 📂 Article 📅 1981 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 514 KB

## Abstract The spectrin‐4.1‐actin complex isolated from the cytoskeleton of human erythrocyte [3] was found to be similar to muscle F‐actin in several aspects: Both the complex and F‐actin nucleate cytochalasin‐sensitive actin polymerization; both bind dihydrocytochalasin B with similar binding co

Active, phosphorylation-dependent MAP ki

Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat

✍ I. Ferrer; R. Blanco; M. Carmona; B. Puig; I. Domínguez; F. Viñals 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 737 KB

The Akt activation inhibitor TCN-P inhib

The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane

✍ Berndt, N; Yang, H; Trinczek, B; Betzi, S; Zhang, Z; Wu, B; Lawrence, N J; Pelle 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 797 KB

Establishment of In Vitro P-Glycoprotein

Establishment of In Vitro P-Glycoprotein inhibition assay and its exclusion criteria to assess the risk of drug–drug interaction at the drug discovery stage

✍ Hiroshi Sugimoto; Shin-ichi Matsumoto; Miho Tachibana; Shin-ichi Niwa; Hideki Hi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

The Role of ErbB3 and its Binding Partne

The Role of ErbB3 and its Binding Partners in Breast Cancer Progression and Resistance to Hormone and Tyrosine Kinase Directed Therapies

✍ Anne W. Hamburger 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 234 KB